Skip to main content


EpiPen® Auto-Injector Supply Update - 22 January 2019

Allergy & Anaphylaxis Australia (A&AA) has received the following from Mylan.

 

EpiPen® Auto-Injector Supply Update

Mylan Australia is pleased to advise patients, pharmacists and prescribers that EpiPen® Adrenaline (epinephrine) Auto-Injector is no longer listed on the Therapeutic Goods Administration’s Drug Shortage webpage.

We believe there is sufficient supply of EpiPen® Adrenaline (epinephrine) Auto-Injector to meet current patient needs in Australia.

Stock at both wholesalers and at Mylan’s warehouse is adequate, and orders from wholesalers and pharmacies are being filled as they are received. 

As a prudent measure to provide an extra safeguard for this critical medicine, Mylan Australia is carefully managing stock levels, including by reviewing orders as they are received. 

Mylan Australia’s dedicated, toll-free EpiPen Customer Service hotline 1800 931 625 remains up and running for any enquiries. 

We will continue to update stakeholders regularly about our supply situation. 

 

EpiPen® Auto-Injector Supply Update - 22 January 2019

IN AN EMERGENCY

If you are having an allergic reaction follow advice on your ASCIA Action Plan.

If in doubt, give the Anapen® or EpiPen®.

Do not call us for emergency advice.

If you do not have an ASCIA Action Plan and/or an Anapen® or EpiPen® call triple zero (000) for an ambulance.